Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2

α-Synuclein is a presynaptic protein that is implicated in Parkinson's and other neurodegenerative diseases. Physiologically, native α-synuclein promotes presynaptic SNARE-complex assembly, but its molecular mechanism of action remains unknown. Here, we found that native α-synuclein promotes clustering of synaptic-vesicle mimics, using a single-vesicle optical microscopy system. This vesicle-clustering activity was observed for both recombinant and native α-synuclein purified from mouse brain. Clustering was dependent on specific interactions of native α-synuclein with both synaptobrevin-2/VAMP2 and anionic lipids. Out of the three familial Parkinson's disease-related point mutants of α-synuclein, only the lipid-binding deficient mutation A30P disrupted clustering, hinting at a possible loss of function phenotype for this mutant. α-Synuclein had little effect on Ca2+-triggered fusion in our reconstituted single-vesicle system, consistent with in vivo data. α-Synuclein may therefore lead to accumulation of synaptic vesicles at the active zone, providing a ‘buffer’ of synaptic vesicles, without affecting neurotransmitter release itself. DOI: http://dx.doi.org/10.7554/eLife.00592.001

[1]  Jiajie Diao,et al.  Properties of native brain α-synuclein , 2013, Nature.

[2]  Patricia Grob,et al.  In vitro system capable of differentiating fast Ca2+-triggered content mixing from lipid exchange for mechanistic studies of neurotransmitter release , 2011, Proceedings of the National Academy of Sciences.

[3]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[4]  Reinhard Jahn,et al.  A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.

[5]  A. Jonas,et al.  Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.

[6]  Ralf Langen,et al.  Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement , 2008, Proceedings of the National Academy of Sciences.

[7]  Patricia Grob,et al.  Synaptic proteins promote calcium-triggered fast transition from point contact to full fusion , 2012, eLife.

[8]  Axel T Brunger,et al.  Studying calcium-triggered vesicle fusion in a single vesicle-vesicle content and lipid-mixing system , 2012, Nature Protocols.

[9]  T. Kuner,et al.  A small pool of vesicles maintains synaptic activity in vivo , 2011, Proceedings of the National Academy of Sciences.

[10]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[11]  Nam Ki Lee,et al.  Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking , 2013, Proceedings of the National Academy of Sciences.

[12]  Michael J. Devine,et al.  Parkinson's Disease and alpha-Synuclein Expression , 2011 .

[13]  T. Ha,et al.  Complexin and Ca2+ stimulate SNARE-mediated membrane fusion , 2008, Nature Structural &Molecular Biology.

[14]  G. Knott,et al.  Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity , 2012, Acta Neuropathologica.

[15]  Richard Paylor,et al.  Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.

[16]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[17]  Leonidas Stefanis,et al.  α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.

[18]  B. Ghetti,et al.  SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. , 2010, Brain : a journal of neurology.

[19]  R. D. Carlson,et al.  A simple method for the preparation of homogeneous phospholipid vesicles. , 1977, Biochemistry.

[20]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[21]  Michael J. Devine,et al.  Parkinson's disease and α‐synuclein expression , 2011, Movement disorders : official journal of the Movement Disorder Society.

[22]  P. Lansbury,et al.  Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants , 2000 .

[23]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[24]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[25]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[26]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[27]  Giuseppe Battaglia,et al.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. S. St George-Hyslop,et al.  alpha-Synuclein membrane interactions and lipid specificity. , 2000, The Journal of biological chemistry.

[29]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[30]  R. Hawkins,et al.  α‐Synuclein produces a long‐lasting increase in neurotransmitter release , 2004, The EMBO journal.

[31]  S. Cragg,et al.  Increased striatal dopamine release and hyperdopaminergic‐like behaviour in mice lacking both alpha‐synuclein and gamma‐synuclein , 2008, The European journal of neuroscience.

[32]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[33]  Richard Wade-Martins,et al.  Functional Alterations to the Nigrostriatal System in Mice Lacking All Three Members of the Synuclein Family , 2011, The Journal of Neuroscience.

[34]  R A Crowther,et al.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Thomas C. Südhof,et al.  Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities , 2012, The Journal of Neuroscience.

[36]  T. Südhof,et al.  Essential functions of synapsins I and II in synaptic vesicle regulation , 1995, Nature.

[37]  T. Ulmer,et al.  α-Synuclein Populates Both Elongated and Broken Helix States on Small Unilamellar Vesicles , 2011, The Journal of Biological Chemistry.

[38]  W. Webb,et al.  Quantification of alpha-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy. , 2006, Biophysical journal.

[39]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Masliah,et al.  A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration , 2010, The Journal of Neuroscience.

[41]  A. Björklund,et al.  Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons , 2012, Proceedings of the National Academy of Sciences.

[42]  T. Südhof,et al.  α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.

[43]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[44]  Wei Wang,et al.  A soluble α-synuclein construct forms a dynamic tetramer , 2011, Proceedings of the National Academy of Sciences.

[45]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[46]  David Eisenberg,et al.  Structures of segments of α‐synuclein fused to maltose‐binding protein suggest intermediate states during amyloid formation , 2011, Protein science : a publication of the Protein Society.

[47]  R. Nicoll,et al.  Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis , 2010, Neuron.

[48]  W. Webb,et al.  Quantification of α-Synuclein Binding to Lipid Vesicles Using Fluorescence Correlation Spectroscopy , 2006 .

[49]  Bernard Schneider,et al.  α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.

[50]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[51]  D. Eliezer,et al.  Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.

[52]  P. Lansbury,et al.  Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease? , 2000, Nature Cell Biology.

[53]  E. Lemke,et al.  Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence , 2009, Proceedings of the National Academy of Sciences.

[54]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[55]  J. Hardy,et al.  Genetic classification of primary neurodegenerative disease. , 1998, Science.

[56]  Erica L. Unger,et al.  Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in mice , 2006, Neurobiology of Disease.

[57]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[58]  P. S. St George-Hyslop,et al.  α-Synuclein Membrane Interactions and Lipid Specificity* , 2000, The Journal of Biological Chemistry.

[59]  D. Eliezer,et al.  A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. , 2003, Journal of molecular biology.

[60]  R. Scheller,et al.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  I. Martin,et al.  Recent advances in the genetics of Parkinson's disease. , 2011, Annual review of genomics and human genetics.

[62]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[63]  Ad Bax,et al.  Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties , 2012, Biochemistry.

[64]  P. Lansbury,et al.  Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. , 2000, Annals of the New York Academy of Sciences.

[65]  C. Joo,et al.  A single vesicle-vesicle fusion assay for in vitro studies of SNAREs and accessory proteins , 2012, Nature Protocols.

[66]  H. Tanila,et al.  Role of α-Synuclein in Presynaptic Dopamine Recruitment , 2004, The Journal of Neuroscience.

[67]  M. Goedert,et al.  Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation* , 1998, The Journal of Biological Chemistry.

[68]  D. Sulzer,et al.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.

[69]  Ad Bax,et al.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. , 2009, Journal of molecular biology.

[70]  H. Tanila,et al.  Role of alpha-synuclein in presynaptic dopamine recruitment. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[72]  A. Bax,et al.  Site-Specific Interaction between α-Synuclein and Membranes Probed by NMR-Observed Methionine Oxidation Rates , 2013, Journal of the American Chemical Society.